| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | ms6024-11 | timept:P21 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-12 | timept:P21 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-13 | timept:P21 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-14 | timept:P21 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-15 | timept:P21 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-1 | timept:P21 | Grouping:K6+/+ | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-2 | timept:P21 | Grouping:K6+/+ | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-3 | timept:P21 | Grouping:K6+/+ | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-4 | timept:P21 | Grouping:K6+/+ | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-5 | timept:P21 | Grouping:K6+/+ | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-16 | timept:P90 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-17 | timept:P90 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-18 | timept:P90 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-19 | timept:P90 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-20 | timept:P90 | Grouping:K6-/- | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-10 | timept:P90 | Grouping:K6+/+ | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-6 | timept:P90 | Grouping:K6+/+ | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-7 | timept:P90 | Grouping:K6+/+ | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-8 | timept:P90 | Grouping:K6+/+ | ng/vial |
| Reversed phase POSITIVE ION MODE | ms6024-9 | timept:P90 | Grouping:K6+/+ | ng/vial |
Return to study ST000858 main page
Download data matrix(Targeted Sphingolipids in Kallikrein 6 Mice after SCI Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|